Status:
RECRUITING
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
Lead Sponsor:
Xiujuan Zang
Conditions:
Hyperkalemia
Chronic Kidney Disease(CKD)
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims...
Detailed Description
Hyperkalemia is a common and life-threatening complication in CKD, with limited data available for non-dialysis patients in community settings. This cross-sectional study will enroll 2,000 non-dialysi...
Eligibility Criteria
Inclusion
- Aged 18 years or older with stable vital signs, specifically defined as:
- Body temperature: 36.0°C-38.0°C;
- Pulse: 50-120 beats/min;
- Respiratory rate: 10-24 breaths/min;
- Blood pressure: Systolic blood pressure ≥90 mmHg and diastolic blood pressure ≥60 mmHg.
- Willing to participate in the study and sign the informed consent form.
- Hematocrit (Hct) level between 25% and 60%.
- Confirmed diagnosis of chronic kidney disease (CKD).
Exclusion
- Patients in the unstable phase of acute cardiovascular or cerebrovascular diseases (e.g., acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome).
- Patients in the unstable phase of severe acute diabetic complications (e.g., diabetic ketoacidosis or hyperosmolar hyperglycemic coma).
- Patients currently in the acute kidney injury (AKI) stage.
- Patients who have started renal replacement therapy.
- Pregnant or breastfeeding women.
- Patients currently participating in or who have participated in other clinical trials within the past six months.
- Patients unable to understand verbal or written instructions, including informed consent content.
- Patients unable to cooperate with the study procedures.
- Other conditions deemed unsuitable for participation in this clinical trial by the investigator.
Key Trial Info
Start Date :
April 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
1890 Patients enrolled
Trial Details
Trial ID
NCT06940414
Start Date
April 28 2025
End Date
September 30 2025
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200025